The DOI matches its Crossref record; 17 of the 19 references it cites were found in a registry or an index.
Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda
Open accessPublished version of a preprint
Abstract
99DOTS is a low-cost digital adherence technology that allows people with tuberculosis (TB) to self-report treatment adherence. There are limited data on its implementation, feasibility, and acceptability from sub-Saharan Africa. We conducted a longitudinal analysis and cross-sectional surveys nested within a stepped-wedge randomized trial at 18 health facilities in Uganda between December 2018 and January 2020. The longitudinal analysis assessed implementation of key components of a 99DOTS-based intervention, including self-reporting of TB medication adherence via toll-free phone calls, automated text message reminders and support actions by health workers monitoring adherence data. Cross-sectional surveys administered to a subset of people with TB and health workers assessed 99DOTS feasibility and acceptability. Composite scores for capability, opportunity, and motivation to use 99DOTS were estimated as mean Likert scale responses. Among 462 people with pulmonary TB enrolled on 99DOTS, median adherence was 58.4% (inter-quartile range [IQR] 38.7–75.6) as confirmed by self-reporting dosing via phone calls and 99.4% (IQR 96.4–100) when also including doses confirmed by health workers. Phone call-confirmed adherence declined over the treatment period and was lower among people with HIV (median 50.6% vs. 63.7%, p<0.001). People with TB received SMS dosing reminders on 90.5% of treatment days. Health worker support actions were documented for 261/409 (63.8%) people with TB who missed >3 consecutive doses. Surveys were completed by 83 people with TB and 22 health workers. Composite scores for capability, opportunity, and motivation were high; among people with TB, composite scores did not differ by gender or HIV status. Barriers to using 99DOTS included technical issues (phone access, charging, and network connection) and concerns regarding disclosure. 99DOTS was feasible to implement and highly acceptable to people with TB and their health workers. National TB Programs should offer 99DOTS as an option for TB treatment supervision.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Phased introduction of the 99DOTS intervention in Kiwanuka et al. 2023 ensured that all clusters eventually received the intervention while enabling a rigorous evaluation of its impact on TB treatment adherence.
“Phased introduction of the 99DOTS intervention, ensuring that all clusters eventually received the intervention while enabling a rigorous evaluation of its impact on TB treatment adherence.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [85]
The Study setting and design section describes a stepped-wedge randomized trial at 18 health facilities, with a 99DOTS intervention period at each facility. It does not explicitly say that every cluster received the intervention. The same section says the parent trial assessed effectiveness against routine care, while the Introduction identifies treatment completion as its reported outcome; this paper assessed adherence during 99DOTS use, not the intervention’s impact on adherence. (LLM, conf=0.84)
Experimental — accuracy not yet measuredHealth facilities in Kiwanuka et al. 2023 were randomly assigned to receive the intervention at different times using a stepped-wedge cluster randomized trial design.
“Health facilities were randomly assigned to receive the intervention at different times using a stepped-wedge cluster randomized trial design.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [85]
The sequence of implementation in Kiwanuka et al. 2023 was randomly determined.
“The sequence of implementation was randomly determined.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [85]
The sample size calculation in Kiwanuka et al. 2023 assumed that 20% of enrolled patients would have TB, and the time from enrollment to TB treatment initiation would be a median of 10 days. The study aimed to have 95% confidence and more than 90% power to detect a minimum of 2 days reduction in time to TB treatment.
“The sample size calculation assumed that 20% of enrolled patients would have TB, and the time from enrollment to TB treatment initiation would be a median of 10 days. The study aimed to have 95% confidence and more than 90% power to detect a minimum of 2 days reduction in time to TB treatment.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [85]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Venkatesh, V., Thong, J. Y. L., & Xu, X. (2012) · MIS Quarterly · doi:10.2307/41410412 · Cited by 15,756
Michie, S., van Stralen, M. M., & West, R. (2011) · Implementation Science · doi:10.1186/1748-5908-6-42 · Cited by 13,697
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Venkatesh, V., Thong, J. Y. L., & Xin, X. (2012) · Journal of the Association for Information Systems · doi:10.5281/zenodo.897039 · Cited by 1,274
Subbaraman, R., de Mondesert, L., Musiimenta, A., Pai, M., Mayer, K. H., Thomas, B. E., & Haberer, J. E. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-001018 · Cited by 264
Unified Theory of Acceptance and Use of Technology (UTAUT) Model-Mobile Banking
Sarfaraz, J. (2017) · RePEc: Research Papers in Economics · Cited by 89
Cattamanchi, A., Crowder, R., Kityamuwesi, A., Kiwanuka, N., Lamunu, M., Namale, C., Tinka, L. K., Nakate, A. S., Ggita, J., Turimumahoro, P., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003628 · Cited by 83
Self-citation99DOTS: a low-cost approach to monitoring and improving medication adherence
Cross, A., Gupta, N., Liu, B., Nair, V., Kumar, A., Kuttan, R., Ivatury, P., Chen, A. Z., Lakshman, K., Rodrigues, R., et al. (2019) · International Conference on Information and Communication Technologies and Development · doi:10.1145/3287098.3287102 · Cited by 62
Thekkur, P., Kumar, A. M. V., Chinnakali, P., Selvaraju, S., Bairy, R., Singh, A. R., Nirgude, A. S., Selvaraj, K., Venugopal, V., & Shastri, S. G. (2019) · Global Health Action · doi:10.1080/16549716.2019.1568826 · Cited by 61
Thomas, B. E., Kumar, J. V., Onongaya, C., Bhatt, S. N., Galivanche, A., Periyasamy, M., Chiranjeevi, M., Khandewale, A. S., Ramachandran, G., Shah, D., et al. (2020) · JMIR mhealth and uhealth · doi:10.2196/16634 · Cited by 60
Thomas, B. E., Kumar, J. V., Chiranjeevi, M., Shah, D., Khandewale, A. S., Thiruvengadam, K., Haberer, J. E., Mayer, K. H., & Subbaraman, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa333 · Cited by 55
Patel, D., Berger, C. A., Kityamuwesi, A., Ggita, J. M., Tinka, L. K., Turimumahoro, P., Feler, J. R., Chehab, L. Z., Chen, A. Z., Gupta, N., et al. (2020) · JMIR Formative Research · doi:10.2196/19270 · Cited by 37
Self-citationChen, A. Z., Kumar, R., Baria, R. K., Shridhar, P. K., Subbaraman, R., & Thies, W. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08418-2 · Cited by 32
Prabhu, A., Agarwal, U., Tripathy, J. P., Singla, N., Sagili, K. D., Thekkur, P., & Sarin, R. (2019) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2019.08.010 · Cited by 24
Crowder, R. R., Kityamuwesi, A., Kiwanuka, N., Lamunu, M., Namale, C., Tinka, L. K., Sanyu, A. N., Ggita, J. M., Turimumahoro, P., Babirye, D., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039895 · Cited by 16
Self-citationOpportunities to improve digital adherence technologies and TB care using human-centered design
Berger, C. A., Patel, D., Kityamuwesi, A., Ggita, J. M., Tinka, L. K., Turimumahoro, P., Neville, K., Chehab, L. Z., Chen, A., Gupta, N., et al. (2020) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.20.0184 · Cited by 14
Self-citation
Flagged first, then by citations
2 of the 19 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- E Efo, 2021, Acceptability, Feasibility and Accuracy of 99DOTS Adherence Technology in Mining Region of Tanzania., 2021 IST-Africa Conference (IST-Africa)
- StataCorp, 2017, Stata Statistical Software: Release 15
Cited by
Sorted by citations
Chen, A. Z., Kumar, R., Baria, R. K., Shridhar, P. K., Subbaraman, R., & Thies, W. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08418-2 · Cited by 32
Chilala, C. I., Foster, N., Bahukudumbi, S., Mohamed, M. S., Zary, M., Kafie, C., Patel, B., Gore, G. C., Schwartzman, K., Subbaraman, R., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-016535 · Cited by 19
Tadesse, A. W., Mganga, A., Dube, T., Alacapa, J., van Kalmthout, K., Letta, T., Mleoh, L., Garfin, A. M. C., Maraba, N., Charalambous, S., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1327971 · Cited by 16
Bai, P., Beversluis, C., Song, A., Alicea, N., Eisenberg, Y., Layden, B. T., Scanzera, A. C., Leifer, A., Musick, H., & Chan, R. V. P. (2024) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000531 · Cited by 5
Madden, N., Tadesse, A. W., Leung, C. L., Tasca, B. G., Alacapa, J., Deyanova, N., Ndlovu, N. T., Mokone, N., Onjare, B., Mganga, A., et al. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10030068 · Cited by 5
Atiku, S. O., & Olakotan, O. O. (2026) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70372 · Cited by 3
Heryanto, E. (2026) · Lentera Perawat · doi:10.52235/lp.v7i1.718 · Cited by 3
Implementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review
Hui, C. Y., Condon, K., Kolekar, S., Roberts, N., Sreter, K. B., Simons, S. O., Figueiredo, C. L., McKeough, Z. J., Salim, H. S., Gawlik‐Lipinski, A., et al. (2026) · Journal of Medical Internet Research · doi:10.2196/88325 · Cited by 2
Triana, R., Pujiyanto, P., & Chandra, E. (2023) · J-KESMAS Jurnal Kesehatan Masyarakat · doi:10.35329/jkesmas.v9i2.4823 · Cited by 2
Therapies for Geographic Atrophy
Gasparian, S. A., Skrehot, H. C., & Weng, C. Y. (2023) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000515 · Cited by 2
Alacapa, J., Tadesse, A. W., Deyanova, N., Dube, T., Mganga, A., Powers, R., van Rest, J., Madden, N., Efo, E., Charalambous, S., et al. (2025) · JMIR Public Health and Surveillance · doi:10.2196/62881 · Cited by 1
Nuwematsiko, R., Kiwanuka, N., Atuyambe, L. M., Wobusobozi, I., Kasiita, V., Kagongwe, S., Ssenyonga, R., Kalyango, J. N., Nankabirwa, V., & Buregyeya, E. (2025) · JMIR Research Protocols · doi:10.2196/70325 · Cited by 1
Self-citationChen, D., Dai, Z., Lin, S., Wei, S., Chen, K., & Deng, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1759922 · Cited by 1
Belachew, M., Sahile, M., Gadissa, D., Abdurhman, T., Bedru, A., McQuaid, C. F., van Rest, J., van Kalmthout, K., Jerene, D., Fielding, K., et al. (2024) · medRxiv · doi:10.1101/2024.03.14.24304331 · Cited by 1
Musa, Z. A., Akinsolu, F. T., Salako, A. O., Abodunrin, O. R., Ola, O. M., & Ezechi, O. C. (2026) · Frontiers in Epidemiology · doi:10.3389/fepid.2026.1529289
Samina, P., Haidar, M. R., Ibrahim, T., Rahman, T., Sarker, M. S., Noor, S. S., Ahmed, S., Uddin, M. K. M., Kabir, S., & Banu, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-24368-7
Yusransyah, Y., Setiawan, D., Mursyid, A., Subchan, M., Stiani, S. N., & Udin, B. (2026) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2026.01.25.8221
Bwambale, K., Amutuheire, D., Nakkonde, D., Kaggwa, P., Nassanga, G., Buregyeya, E., Nabukeera, S., Nabukeera, S., Isunju, J. B., & Sekandi, J. N. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1815509
Metadata
- Authors
- Kiwanuka, N., Kityamuwesi, A., Crowder, R., Guzman, K., Berger, C. A., Lamunu, M., Namale, C., Kunihira Tinka, L., Nakate, A. S., Ggita, J., Turimumahoro, P., Babirye, D., Oyuku, D., Patel, D., Sammann, A., Turyahabwe, S., Dowdy, D. W., Katamba, A., & Cattamanchi, A.
- Affiliations
- Makerere University (UG)
- San Francisco General Hospital (US)
- University of California, San Francisco (US)
- Ministry of Health (UG)
- Johns Hopkins University (US)
- Corresponding author
- Cattamanchi, Adithya
- ORCID
- Venue
- PLOS Digital Health
- Publisher
- Public Library of Science (PLoS)
- Published
- 2023-06-30
- Volume
- 2
- Issue
- 6
- Pages
- e0000138
- ISSN
- 2767-3170 (ISSN-L)
- PMC
- PMC10313004
- OpenAlex
- W4382752395
- Cited by
- 17
- References
- 19
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 4 · 2023: 3
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLOS Digital Health (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Stop TB Partnership (STBP/TBREACH/GSA/W6-37)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- drug-susceptible tuberculosis, medication adherence, SMS reminders, health worker support, HIV coinfection, implementation feasibility, acceptability, technology adoption barriers, Uganda
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review